Statistics for Safety effectiveness and immunogenicity of heterologous mRNA1273 boost after prime with Ad26COV2S among healthcare workers in South Africa The singlearm openlabel phase 3 SHERPA study
Total visits
| views | |
|---|---|
| Safety effectiveness and immunogenicity of heterologous mRNA1273 boost after prime with Ad26COV2S among healthcare workers in South Africa The singlearm openlabel phase 3 SHERPA study | 4 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 4 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Journal Article.pdf | 5 |